This proposal is to study the role of metablastin, a highly conserved cytosolic protein involved in signal transduction, in the control of mammalian cell division. Metablastin is expressed in many immature cells during development and in most cancer cells. It is strongly induced in lymphocytes after exposure to mitogens and in hepatocytes during liver regeneration. Metablastin undergoes serine phosphorylation in response to a variety of extracellular factors and during mitosis, at sites that serve as substrates for both cyclin-dependent (CDKs) and mitogen- activated protein kinases (MAPKs/ERKs) in vitro. Conditional expression of a phosphorylation site mutant of metablastin in human leukemia cells was recently shown to result in cell cycle arrest at the G2/M interface, suggesting that metablastin plays a role in the control of the G2/M transition. Guided by structural features of metablastin, we have isolated a human metablastin-interacting protein, Mip1, using a yeast two-hybrid interaction screen. Mip1 is novel but may be related to the dbl proto-oncogene family of guanine nucleotide exchange factors for certain Ras-related GTP-binding proteins. The hypothesis we wish to test is that the interaction of metablastin with Mip1 is part of a cell cycle control switch that is operated through phosphorylation of metablastin by the cyclin-dependent protein kinase p34cdc2. The first specific aim is to characterize Mip1. We will isolate and sequence full-length human and murine cDNAs encoding Mip1. Putative functional motifs will then be tested in vitro using recombinant Mip1. Once a functional activity has been identified, we will test if it is altered in the presence of phosphorylated or non-phosphorylated metablastin. We will raise antibodies to Mip1 and study the expression of the protein and its mRNA in murine tissues during development. To explore the biological function of Mip1 and the functional significance of its interaction with metablastin, we will carry out microinjection studies using HeLa cells. In these studies, we will compare the ability of phosphorylation site mutants of metablastin and of Mip1 antibodies to induce cell cycle arrest. To further explore if Mip1 is a critical cellular target of metablastin, we will test if co-injection of Mip1 will reverse the inhibitory effect of metablastin mutants on the cell cycle. We will also express full-length and truncated forms of Mip1 in NIH-3T3 cells in order to test the oncogenic potential of Mip1. In addition, we will use the yeast two-hybrid system to search for interacting proteins that might be potential downstream targets or upstream regulators of Mip1. The second specific aim is to study the interaction of metablastin and Mip1 in vitro and in vivo and to explore if site-specific phosphorylation of metablastin alters this interaction. A more long-range aim is to determine, using the yeast two-hybrid interaction screen, if there is a family of metablastin-interacting proteins. The proposed studies promise to shed light on a novel mechanism in the control cell replication, perturbations of which may play a role in oncogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS026333-08
Application #
2668993
Study Section
Neurology C Study Section (NEUC)
Program Officer
Leblanc, Gabrielle G
Project Start
1988-07-01
Project End
2000-02-29
Budget Start
1998-03-01
Budget End
1999-02-28
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Liedtke, Wolfgang; Leman, Elizabeth E; Fyffe, Robert E W et al. (2002) Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems. Am J Pathol 160:469-80
Horwitz, S B; Shen, H J; He, L et al. (1997) The microtubule-destabilizing activity of metablastin (p19) is controlled by phosphorylation. J Biol Chem 272:8129-32
Schubart, U K; Yu, J; Amat, J A et al. (1996) Normal development of mice lacking metablastin (P19), a phosphoprotein implicated in cell cycle regulation. J Biol Chem 271:14062-6
Mock, B A; Krall, M M; Padlan, C et al. (1993) The gene for Lap18, leukemia-associated phosphoprotein p18 (metablastin), maps to distal mouse chromosome 4. Mamm Genome 4:461-2
Labdon, J E; Nieves, E; Schubart, U K (1992) Analysis of phosphoprotein p19 by liquid chromatography/mass spectrometry. Identification of two proline-directed serine phosphorylation sites and a blocked amino terminus. J Biol Chem 267:3506-13
Schubart, U K; Xu, J; Fan, W et al. (1992) Widespread differentiation stage-specific expression of the gene encoding phosphoprotein p19 (metablastin) in mammalian cells. Differentiation 51:21-32
Pampfer, S; Fan, W; Schubart, U K et al. (1992) Differential mRNA expression of the phosphoprotein p19/SCG10 gene family in mouse preimplantation embryos, uterus, and placenta. Reprod Fertil Dev 4:205-11
Amat, J A; Fields, K L; Schubart, U K (1991) Distribution of phosphoprotein p19 in rat brain during ontogeny: stage-specific expression in neurons and glia. Brain Res Dev Brain Res 60:205-18
Amat, J A; Fields, K L; Schubart, U K (1990) Stage-specific expression of phosphoprotein p19 during spermatogenesis in the rat. Mol Reprod Dev 26:383-90
Schubart, U K; Banerjee, M D; Eng, J (1989) Homology between the cDNAs encoding phosphoprotein p19 and SCG10 reveals a novel mammalian gene family preferentially expressed in developing brain. DNA 8:389-98